Title : Lovastatin inhibits VEGFR and AKT activation: synergistic cytotoxicity in combination with VEGFR inhibitors.

Pub. Date : 2010 Sep 3

PMID : 20838437






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Lovastatin inhibits VEGFR and AKT activation: synergistic cytotoxicity in combination with VEGFR inhibitors. Lovastatin AKT serine/threonine kinase 1 Homo sapiens
2 Lovastatin attenuated ligand-induced receptor activation and downstream signaling through the PI3K/AKT pathway. Lovastatin AKT serine/threonine kinase 1 Homo sapiens
3 In this study, we have shown that lovastatin inhibits ligand-induced VEGFR-2 activation through inhibition of receptor internalization and also inhibits VEGF activation of AKT in human umbilical vein endothelial cells (HUVEC) and H28 MM cells employing immunofluorescence and Western blotting. Lovastatin AKT serine/threonine kinase 1 Homo sapiens
4 Combinations of lovastatin and a VEGFR-2 inhibitor showed more robust AKT inhibition than either agent alone in the H28 MM cell line. Lovastatin AKT serine/threonine kinase 1 Homo sapiens